Spero Therapeutics and partner GSK are stopping a late-stage trial of an experimental oral drug for complicated urinary tract ...

UTIs are among the most common infections worldwide, affecting some 15 million women a year. Phenazopyridine, sold under brand names such as Azo and Uristat, is used to treat the pain, burning and ...

Patterson-UTI Energy, Inc. ( NASDAQ:PTEN ) will pay a dividend of $0.08 on the 16th of June. The dividend yield will ...

Major health sector news includes GSK and Spero stopping a UTI drug trial due to early success, Brazil's bird flu cases and ...

Recent health news highlights include GSK and Spero halting a UTI drug trial after achieving success, Sanofi exploring ...

Watford MP Matt Turmaine emphasised the urgent need for a cure for chronic urinary tract infections (UTIs) at Parliament last ...

Continuing the conversation from the SWLS stage, if you've got questions, but you're lacking in courage, start here.

GSK’s decision to swoop in and save Spero Therapeutics’ antibiotic three years ago appears to have paid off based on a fresh ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even ...

Universal Technical Institute plans to open new San Antonio campus for skilled trades. Students can pursue HVAC, welding, ...

Spero Therapeutics (SPRO) stock jumps as GSK (GSK) partnered oral UTI treatment, tebipenem HBr, succeeds in a pivotal Phase 3 ...